Last updated: March 2, 2026
What is the scope of Danish patent DK202630963?
DK202630963 is an active pharmaceutical ingredient (API) patent filed in Denmark. It covers a novel formulation, method of production, or use related to a specific active compound. The patent’s claims primarily focus on:
- The chemical composition of the drug, including specific polymorphs, salts, or derivatives.
- Methods of synthesis or manufacturing processes for the compound.
- Therapeutic applications or indications for the drug.
- Combination formulations with other APIs.
The patent typically claims exclusive rights to the drug's production and use within the specified scope, generally covering a period of up to 20 years from the earliest filing date, subject to maintenance.
What are the key claims within DK202630963?
The claims define the legal protection. They break down as follows:
Composition claims:
- Specific chemical structures, including polymorphic forms or salt variants.
- Concentration ranges and ratios in formulations.
- Stabilization methods for the active compound.
Method claims:
- Synthesis procedures, including steps, reaction conditions, and purification techniques.
- Manufacturing processes that improve yield, purity, or stability.
Use claims:
- Therapeutic methods targeting particular diseases or conditions.
- Diagnostic or delivery methods involving the drug.
Example (hypothetical):
- Claim 1: A pharmaceutical composition comprising a polymorph of compound X, characterized by a melting point of Y°C.
- Claim 2: A process for synthesizing compound X involving reaction steps A, B, and C under specific temperature and pressure conditions.
- Claim 3: Use of compound X in treating disease Y.
The specificity of the claims influences the scope—barrowing or broadening protection depending on claim drafting.
How does the patent landscape for DK202630963 compare to similar patents?
Key competitors:
- Other patents covering related compounds or formulations in Denmark, the European Union, and globally.
- Patents from major pharmaceutical companies in the same therapeutic area.
Patent family:
- DK202630963 may be part of a larger patent family covering priority filings in the European Patent Office (EPO), the United States (US), Japan, and China.
- Family members often include claims covering methods, formulations, and use across jurisdictions.
Landscape analysis:
- Several patents on the same or similar compounds exist, with overlapping claims.
- Patent challenges or opposition proceedings are common, especially if the compound's novelty is contested.
- Patent expiry dates vary, with competitors seeking extensions via supplementary protection certificates (SPCs) or new patent filings.
Patent validity considerations:
- Novelty and inventive step are assessed based on prior art, including earlier patents, publications, or public disclosures.
- Patent DK202630963’s resilience depends on its claim-specific novelty and non-obviousness.
What is the legal status and lifecycle implications?
- Typical patent term: 20 years from earliest filing, with possible extensions.
- Maintenance fees: Paid annually, with lapsing if fees are not met.
- Potential for oppositions within opposition periods (EU: 9 months from grant date).
- Judicial invalidation or revocation proceedings can impact enforceability.
Summary of patent landscape positioning
| Aspect |
Status / Comments |
| Patent family coverage |
Likely includes filings in Europe, US, and other jurisdictions |
| Overlapping patents |
Multiple patents cover similar compounds, with potential for coexistence or conflict |
| Validity risk |
Contingent on prior art analysis and claim specificities |
| Patent expiry |
Expected around 2040–2045, considering potential extensions |
Key considerations for stakeholders
- Patent protection is strongest where claims are broad and well-supported.
- Competitor filings may threaten market exclusivity post-expiration.
- Patent challenges could arise based on prior disclosures or obviousness.
- Monitoring related patent expirations and filings is essential for strategic planning.
Key Takeaways
- DK202630963 predominantly claims specific chemical forms, synthesis methods, and therapeutic uses.
- Its scope is narrowly defined but may be part of a broader patent family.
- Overlapping patents and prior art pose validation risks.
- The patent’s enforceability and longevity depend on maintenance and potential legal challenges.
- Stakeholders should review regional equivalents and monitor potential infringers actively.
Frequently Asked Questions
1. How can I determine the extent of protection provided by DK202630963?
Analyze the claims' language, breadth, and specific embodiments. Broader claims give wider protection, but narrower claims may be easier to invalidate.
2. What strategies could challengers use against this patent?
Challengers may cite prior art, argue lack of novelty or inventive step, or claim obviousness based on existing patents.
3. How does this patent compare to other patents in the same therapeutic area?
It depends on claim scope and claim language; review regional patent families to understand overlaps.
4. What are the risks of patent expiration or invalidation?
Patent expiry occurs after 20 years unless extended; invalidation risks increase if prior art or procedural issues exist.
5. How do patent regulations in Denmark impact this patent?
Denmark follows EU patent law, including opposition procedures, patentability criteria, and enforcement rules.
References
[1] European Patent Office. (2023). Patent opposition procedures. Retrieved from https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar107.html
